1-11 of 11
Safiya Abouzaid
Close
Sort by
Journal Articles

Morbid Progression Is Common Among Patients with Multiple Myeloma and Is Associated with Shortened Overall Survival: Validation of the Progression-Free Survival Endpoint

Aaron Seth Rosenberg, MD, Thierry Facon, MD, Safiya Abouzaid, MPH, PharmD, Shankar Srinivasan, PhD, Weiyuan Chung, Kejal Parikh, BSPharm, MS, Joseph Tuscano, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3113.
https://doi.org/10.1182/blood.V130.Suppl_1.3113.3113
Published: 2017
Journal Articles

Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma Post Autologous Stem Cell Transplant: A Comparison of Real-World Treatment Outcomes and Costs

Parameswaran Hari, MD MRCP, MS, Brian Ung, PharmD, Safiya Abouzaid, MPH, PharmD, Quanhong Ni, MS, Kejal Parikh, BSPharm, MS, Amit Agarwal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2189.
https://doi.org/10.1182/blood.V130.Suppl_1.2189.2189
Published: 2017
Journal Articles

Real-World Treatment Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with Triplet Therapy without Stem Cell Transplant: An Enhanced Electronic Health Records Database

Ajai Chari, MD, Brian Ung, PharmD, Safiya Abouzaid, MPH, PharmD, Quanhong Ni, MS, Kejal Parikh, BSPharm, MS, Amit Agarwal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2190.
https://doi.org/10.1182/blood.V130.Suppl_1.2190.2190
Published: 2017
Journal Articles

Using an Enhanced Electronic Heath Record to Analyze Treatment Patterns and Clinical Characteristics in Patients with Relapsed or Refractory Multiple Myeloma Receiving Pomalidomide

Ali McBride, PharmD,MS, Zoe Clancy, MS, PharmD, Jorge Mouro, MS, Marc Tian, PhD MPH, Safiya Abouzaid, MPH, PharmD, Joshua R Richter, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5673.
https://doi.org/10.1182/blood.V130.Suppl_1.5673.5673
Published: 2017
Journal Articles

Real-World Outcomes for Maintenance Treatment Sequencing after Receiving Lenalidomide, Bortezomib, and Dexamethasone Induction in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Followed By Autologous Stem Cell Transplant (ASCT)

Rafael Fonseca, MD, Kejal Parikh, BSPharm, MS, Brian Ung, PharmD, Quanhong Ni, MS, Safiya Abouzaid, MPH, PharmD, Amit Agarwal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3463.
https://doi.org/10.1182/blood.V130.Suppl_1.3463.3463
Published: 2017
Journal Articles

Racial Disparities in Treatment Patterns and Outcomes Among Patients with Multiple Myeloma: A SEER-Medicare Analysis

Sikander Ailawadhi, Kejal Parikh, BSPharm, MS, Zhou Zhou, MS, Wenxi Tang, MS, Zoe Clancy, MS, PharmD, Claudia Cheung, MS, Zheng-Yi Zhou, PhD, Jipan Xie, MD PhD, Safiya Abouzaid, MPH, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3426.
https://doi.org/10.1182/blood.V130.Suppl_1.3426.3426
Published: 2017
Journal Articles

Real-World Trends in Treatment Use, Healthcare Costs, and Overall Survival Among Patients with Multiple Myeloma

Rafael Fonseca, Safiya Abouzaid, Machaon Bonafede, Qian Cai, Kejal Parikh, Leon Cosler, Paul Richardson
Journal: Blood
Blood (2016) 128 (22): 3558.
https://doi.org/10.1182/blood.V128.22.3558.3558
Published: 2016
Journal Articles

Matching-Adjusted Indirect Comparison of Relative Efficacies Is Feasible and Useful in the Multiple Myeloma Therapy Landscape: A Comparison of Pomalidomide Plus Low-Dose Dexamethasone Versus Daratumumab

Kejal Parikh, Irina Proskorovsky, MSc, Safiya Abouzaid, Stanimira Krotneva, MSc, Veronique Page, MSc, Christopher G Pelligra, BA, Shien Guo, PhD, Jorge L Mouro, Sikander Ailawadhi, MD
Journal: Blood
Blood (2016) 128 (22): 5946.
https://doi.org/10.1182/blood.V128.22.5946.5946
Published: 2016
Journal Articles

Treatment Patterns Among Newly Diagnosed Multiple Myeloma Patients in the United States Veteran Population (2010-2015)

Kejal Parikh, Shivani Pandya, MS, Safiya Abouzaid, Onur Baser, MS, PhD, Lin Xie, MA, MS, Manali I. Patel, MD MPH, MS
Journal: Blood
Blood (2016) 128 (22): 5952.
https://doi.org/10.1182/blood.V128.22.5952.5952
Published: 2016
Journal Articles

Real World Treatment Outcomes and Cost Among Newly-Diagnosed Multiple Myeloma Patients Treated with Bortezomib and Dexamethasone in Combination with Cyclophosphamide or Lenalidomide

Lin Xie, MA, MS, Kejal Parikh, Safiya Abouzaid, Shivani Pandya, MS, Onur Baser, MS, PhD, Manali I. Patel, MD MPH, MS
Journal: Blood
Blood (2016) 128 (22): 5924.
https://doi.org/10.1182/blood.V128.22.5924.5924
Published: 2016
Journal Articles

Assessing the Effect of Injectable or Oral Routes of Treatment Administration on Patient-Reported Outcomes and out-of-Pocket Costs Among Patients with Multiple Myeloma

Shaloo Gupta, MS, Safiya Abouzaid, Ryan Liebert, MS, Kejal Parikh, Aaron S Rosenberg, MD MS
Journal: Blood
Blood (2016) 128 (22): 5931.
https://doi.org/10.1182/blood.V128.22.5931.5931
Published: 2016